NCT06320379

Zypan Functional Dyspepsia

Evaluating Changes in Quality of Life and Digestion in Functional Dyspepsia in Adults

• Status: Unknown
• Phase: N/A
• Study type: Interventional
• Enrollment: 64 (estimated)
• Sponsor: National University of Natural Medicine · Academic / Other
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to determine the effects of a readily available dietary supplement on quality of life and digestion in adults with functional dyspepsia.

Conditions

• Dyspepsia

Interventions

Type	Name	Description
DIETARY_SUPPLEMENT	Zypan	The study product is a dietary supplement manufactured by Standard Process Inc (i.e., Zypan®). One serving (i.e., two tablets) contains a proprietary blend (595 mg) of the following: Betaine hydrochloride, bovine pancreas Cytosol™ extract, pepsin (1:10,000), pancreatin (3x), stearic acid (vegetable source), ammonium chloride, bovine spleen, and ovine spleen. Non active ingredients will include cellulose and calcium stearate. Participants will be instructed to take two tablets three times daily with meals
DIETARY_SUPPLEMENT	Placebo Comparator	The control supplement will not contain any of the active ingredients in Zypan® and will also be manufactured by Standard Process Inc. Two tablets will contain 435 mg of cellulose (42%), 288 mg rice bran powder (28%), 201 mg of calcium lactate powder (19.5%\*), 103 mg citric acid (10%), and 2.6 mg calcium stearate (0.25%)

Timeline

• Start date: 2023-03-15
• Primary completion: 2024-12-31
• Completion: 2024-12-31
• First posted: 2024-03-20
• Last updated: 2024-08-06

Locations

1 site across 1 country: United States